Oral progesterone for the treatment of menopausal symptoms a review of the clinical evidence
The purpose of this review is to examine the clinical efficacy of micronized progesterone (Prometrium), a natural, bio-identical hormone, and methoxyprogesterone acetate (MPA; Provera), a synthetic hormone, individually and comparatively, for the management of menopausal symptoms
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2014, 29 April 2014
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this review is to examine the clinical efficacy of micronized progesterone (Prometrium), a natural, bio-identical hormone, and methoxyprogesterone acetate (MPA; Provera), a synthetic hormone, individually and comparatively, for the management of menopausal symptoms |
|---|---|
| Item Description: | Title from PDF caption. - "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (16 pages) illustration |